Home  »  Company  »  GlaxoSmithKline Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of GlaxoSmithKline Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2017 Mar 31, 2016 Mar 31, 2015 Dec 31, 2013 Dec 31, 2012
Operating Income 2,994.51 2,756.96 3,287.58 2,546.15 2,630.30
Manufacturing Expenses 27.82 25.97 31.17 23.85 13.75
Personnel Expenses 483.01 443.37 493.02 362.05 295.52
Selling Expenses 0 0 0 0 0
Administrative Expenses 663.75 572.55 624.38 476.19 400.50
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 2,574.57 2,279.61 2,660.39 2,024.07 1,811.17
Operating Profit 419.93 477.35 627.19 522.08 819.14
Other Recurring Income 71.76 121.83 198.67 200.97 193.48
Adjusted PBDIT 491.70 599.18 825.86 723.05 1,012.62
Financial Expenses 0 0 0 0 0
Depreciation 26.35 24.78 25.35 19.88 17.84
Other Write offs 0 0 0 0 0
Adjusted PBT 465.35 574.40 800.50 703.17 994.78
Tax Charges 174.30 201.80 276.98 227.44 269.30
Adjusted PAT 291.04 372.60 523.53 475.73 725.48
Non Recurring Items 45.73 2.61 -51.88 26.15 -148.22
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 336.78 375.21 471.65 501.88 577.26
Equity Dividend 337.30 337.30 421.62 352.32 359.85
Preference Dividend 0 0 0 0 0
Retained Earnings 1,153.28 838.94 1,042.18 1,221.31 1,264.34

Find IFSC